{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Answers from the Lab","title":"Assay stratifies pregnant women's preeclampsia risk: Joshua Bornhorst, Ph.D.","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/b36ecd38\"></iframe>","width":"100%","height":180,"duration":310,"description":"Joshua Bornhorst, Ph.D., explains how Mayo Clinic Laboratories' unique blood test identifies pregnant women at risk of developing preeclampsia with severe features. Test results can guide clinical management, to safeguard maternal and neonatal health.\nSpeaker 3: (00:32)\nCan you share a little about yourself and your background?\n \nSpeaker 3: (01:00)\nCan you provide us with an overview of this new preeclampsia assay?\n \nSpeaker 3: (02:33)\nCan you share what will be reported with this assay?\n \nSpeaker 3: (03:07)\nWhich patients should have this testing and at what point should it be performed?\n \nSpeaker 3: (03:35)\nCan you share what alternative test options are available today for preeclampsia?\n \nSpeaker 3: (03:52)\nHow are the test results used in patient care?","thumbnail_url":"https://img.transistorcdn.com/jhRCftFebxnTMwoIbA_WoqrSKwFRD_Y2kbh0JDjhx14/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjNj/ZDc0NTE0MWNlOWRl/YzRiN2Q3NDg2Mjg5/YWE4MS5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}